+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RNA Therapy"

MicroRNA Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

MicroRNA Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
From
From
From
From
From
From
From
mRNA Therapeutics and Vaccines: Key Opinion Leaders - Product Thumbnail Image

mRNA Therapeutics and Vaccines: Key Opinion Leaders

  • Report
  • September 2021
  • 116 Pages
  • Global
From
mRNA Therapeutics and Vaccines Market, 2020-2030 - Product Thumbnail Image

mRNA Therapeutics and Vaccines Market, 2020-2030

  • Report
  • January 2021
  • 253 Pages
  • Global
From
From
Investor Series: Opportunities in RNA Therapeutics Market - Product Thumbnail Image

Investor Series: Opportunities in RNA Therapeutics Market

  • Report
  • March 2023
  • 174 Pages
  • Global
From
Loading Indicator

RNA therapy is a form of gene therapy that uses RNA molecules to treat or prevent diseases. It is a type of genomics-based therapy that works by introducing genetic material into cells to modify their behavior. RNA therapy can be used to treat a variety of diseases, including cancer, neurological disorders, and infectious diseases. It has the potential to be used to treat genetic disorders, as well as to modify the expression of genes in order to improve the effectiveness of existing treatments. RNA therapy works by introducing genetic material into cells, which can then be used to modify the expression of genes. This can be done by introducing a gene that produces a therapeutic protein, or by introducing a gene that silences a gene that is causing a disease. RNA therapy can also be used to modify the expression of existing genes, which can be used to improve the effectiveness of existing treatments. RNA therapy is an emerging field of genomics-based therapy, and is being explored by a number of companies. Examples of companies in the RNA therapy market include Moderna, BioNTech, and Arcturus Therapeutics. Show Less Read more